Gale Partners With Royal Collection Trust to Digitise State Papers of Queen Victoria and King Edward VII February 27, 2026 Historic papers made available online for the first time, offering new insight into Victorian and Edwardian Britain
Lyten Completes Acquisition of Northvolt Sweden and Establishes its First Lyten Industrial Hub in Sweden February 27, 2026 Lyten announces it has completed the acquisition of Northvolt’s battery assets in Sweden, totaling nearly $5B in value. The Skellefteå battery site, Northvolt Ett, is resuming operations and plans to deliver commercial cells in 2H 2026. Lyten announces the establishment of the Lyten Industrial Hub in Skellefteå, Sweden to co-locate battery manufacturing, data centers, and additional manufacturing activities. In connection with the closing, EdgeConneX, a portfolio company of EQT, plans to acquire a data center site from Lyten, with potential capacity of up to one gigawatt.
Musaffa Expands Faith-Aligned Investing With Their Global Halal Investment Platform for US Markets February 26, 2026 Musaffa, a leading fintech platform dedicated to Shariah-compliant investment research and Islamic Finance Education, recently announced the launch of its Global Halal Investment Platform. This new platform provides 600,000+ Muslim investors across 200+ countries with expanded access to US capital markets via regulated and scalable trading and investment infrastructure while embedding Shariah compliance directly into [...]
New Study from Icertis and World Commerce & Contracting Dispels AI Disillusionment Myth February 26, 2026 Fourth Annual AI Survey Reveals Contract Value as Strategic Driver
White Oak Commercial Finance Provides $35 Million ABL Facility to Unicat Catalyst Technologies February 26, 2026 White Oak Commercial Finance (“WOCF”) and White Oak UK (“WOUK”), affiliates of White Oak Global Advisors, today announced they provided a $35 million Asset-Based Lending (ABL) Revolver Facility to Unicat Catalyst Technologies LLC (“Unicat” or “the Company”), a leading supplier of heterogeneous catalyst products. The facility also includes a $20 million uncommitted accordion feature. Headquartered [...]
GoldState Music and Bridgepoint Announce Strategic Partnership Targeting Growth Investments February 26, 2026 Capital will support GoldState Music’s Growth Strategy which will invest in scalable, profitable music-oriented businesses across the music value chain Bridgepoint commits a significant investment as lead investor in GoldState’s Growth Strategy
Fourth Launches Fourth iQ 3.0, Giving Senior Restaurant Leaders Control and Visibility Over Store Performance February 26, 2026 Fourth, the leading provider of workforce and inventory management solutions for the hospitality industry, today announced the launch of Fourth iQ 3.0, introducing a significant new layer of above-store AI capabilities built for executives and operations teams responsible for multi-location performance. The release complements Fourth iQ’s in-store AI capabilities, including Forecasting and Next Best Actions, [...]
Lone Star Agrees to Acquire Central London Office Building February 26, 2026 Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Real Estate Fund VII, L.P. has reached an agreement to acquire 90 Whitfield Street in London, UK from Derwent London. The property, located in central London’s West End sub-market of Fitzrovia, is comprised of 107,000 total square-feet with 99,000 square-feet dedicated to [...]
CoStar Data Show Sharp London Office Yield Compression in 2025 February 26, 2026 Rising investor demand drove London office yields to their lowest level since 2023, according to data from CoStar, a global leading provider of online real estate marketplaces, information and analytics in the property markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260226000995/en/ Based on a three-period trailing average, the transaction-based office yield [...]
ViiV Healthcare presents pipeline data for two investigational HIV treatment therapies with potential for twice-yearly dosing February 25, 2026 VH184, the first, third‑generation integrase inhibitor in development shows potential for up to twice-yearly dosing intervals Additional in-vitro data on VH184 demonstrate improved potency and an enhanced resistance profile versus bictegravir VH499 demonstrates good tolerability, supporting twice-yearly dosing intervals